Abstracts

Poster Presentation Dates

All odd numbered posters will be presented on Friday, November 8, 2019, while even numbered posters will be presented on Saturday, November 9, 2019.

Posters will be on display from 7 a.m. - 8 p.m., with the presenting authors required to be at their posters during lunch (12:30 - 2 p.m. on Friday, Nov. 8, and 12:35 - 2:05 p.m. on Saturday, Nov. 9) and also during the poster reception (6:30 - 8p.m. on Friday, Nov. 8, and 7 - 8:30 p.m. on Saturday, Nov. 9).

#	Title	Authors	Category	Keywords
P609	Fc-silenced bispecific antibodies targeting PD-L1 and 4-1BB combine checkpoint blockade and T-cell co-stimulation to promote anti-tumor activity	Alexander Muik, PhD; Isil Altintas, PhD; Friederike Gieseke; Theodora Salcedo; Saskia Burm; Mustafa Diken; Christian Grunwitz; Danita Schuurhuis; Sebastian Kreiter; David Satijn; Özlem Türeci; Esther Breij, PhD; Ugur Sahin; Maria Jure-Kunkel;	Immune-stimulants and immune modulators	Antibody; Checkpoint blockade; Costimulation
P620	Complementary effects of RNA encoded, extended half-life IL2 and IL7 synergize in modulating T cell responses and antitumoral efficacy.	Lena M. Kranz; Lena M. Kranz; Mathias Vormehr, PhD; Jan Dieckmann, PhD; Claudia Lindemann; David Eisel; Alexander Muik, PhD; Sina Fellermeier-Kopf; Friederike Gieseke; Bodo Tillmann; Sonja Witzel; Marlen Lepper; Mustafa Diken; Sebastian Kreiter, MD; Veronika Jahndel; Özlem Türeci; Ugur Sahin;	Immune-stimulants and immune modulators	Cytokine; Immune adjuvant; T cell; Vaccine
P626	Substantial improvement of cancer immunotherapy by an RNA encoded extended half-life Interleukin-2 variant.	Mathias Vormehr, PhD; Lena M. Kranz; Alexander Muik, PhD; Sina Fellermeier-Kopf; Nadja Salomon; Jan Diekmann; Claudia Lindemann; Sonja Witzel; Marlen Lepper; Friederike Gieseke; Veronika Jahndel; Özlem Türeci; Ugur Sahin;	Immune-stimulants and immune modulators	Checkpoint blockade; Cytokine; Immune adjuvant; Neoantigens; Regulatory T cell (Treg cell); Solid tumors; T cell; Tumor antigens; Vaccine